Related Experiment Videos
Radiation doses received in the UK Breast Screening Programme in 2001 and 2002.
K C Young1, A Burch, J M Oduko
1National Co-ordinating Centre for the Physics of Mammography, Medical Physics Department, Royal Surrey County Hospital, Guildford GU2 7XX, UK.
The British Journal of Radiology
|February 26, 2005
Summary
UK mammography screening doses remain stable, with advanced technology reducing radiation for larger breasts. Quality control ensures most units stay below recommended limits, though total dose per woman increased with two-view screening.
Area of Science:
- Radiology
- Medical Physics
- Public Health
Background:
- Routine mammographic screening in the UK Breast Screening Programme (NHSBSP) involves regular measurement of mean glandular doses (MGD).
- Previous studies established baseline MGDs for mammography within the NHSBSP.
Purpose of the Study:
- To review a large dataset of MGD measurements from UK mammographic screening centres.
- To assess current radiation doses and compare them with previous findings and established reference levels.
Main Methods:
- Analysis of 53,218 mammograms from 16,505 women screened between 2001-2002, using 290 X-ray sets.
- Comparison of MGDs across different views, breast sizes, age groups, and X-ray equipment.
Main Results:
- Average MGD was 2.23 mGy (oblique) and 1.96 mGy (craniocaudal), similar to 1997-1998 levels.
- Advanced equipment reduced doses for large breasts; 97% of units were below the 2 mGy upper limit.
- Total dose per woman increased due to two-view screening, but the proposed NDRL of 3.5 mGy proved appropriate for identifying high-dose systems.
Conclusions:
- Mammography doses in the NHSBSP are generally well-controlled, with technological advancements benefiting patients with larger breasts.
- While overall dose per woman has risen with screening protocols, the established National Diagnostic Reference Level is effective.
- A revised definition of the 'standard breast' is needed to accurately reflect clinical practice and optimize dose monitoring.